FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16203811000001107: Lustral 50mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57139601000001114 Lustral 50mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57139701000001116 Lustral 50mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lustral 50mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Is a Sertraline 50mg tablets false Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Is a Sertraline 50mg tablets true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Is a Product containing precisely sertraline 50 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has active ingredient Sertraline false Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has specific active ingredient Sertraline hydrochloride true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sertraline true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Is a Lustral true Inferred relationship Existential restriction modifier
Lustral 50mg tablets (Lexon (UK) Ltd) Has basis of strength substance Sertraline true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lustral 50mg tablets (Lexon (UK) Ltd) 28 tablet Has AMP True Lustral 50mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start